Idro Richard, Ndiritu Moses, Ogutu Bernhards, Mithwani Sadik, Maitland Kathryn, Berkley James, Crawley Jane, Fegan Gregory, Bauni Evasius, Peshu Norbert, Marsh Kevin, Neville Brian, Newton Charles
Centre for Geographic Medicine Research, Kenya Medical Research Institute/Wellcome Trust Research Labs, Kilifi, Kenya.
JAMA. 2007 May 23;297(20):2232-40. doi: 10.1001/jama.297.20.2232.
Plasmodium falciparum appears to have a particular propensity to involve the brain but the burden, risk factors, and full extent of neurological involvement have not been systematically described.
To determine the incidence and describe the clinical phenotypes and outcomes of neurological involvement in African children with acute falciparum malaria.
DESIGN, SETTING, AND PATIENTS: A review of records of all children younger than 14 years admitted to a Kenyan district hospital with malaria from January 1992 through December 2004. Neurological involvement was defined as convulsive seizures, agitation, prostration, or impaired consciousness or coma.
The incidence, pattern, and outcome of neurological involvement.
Of 58,239 children admitted, 19,560 (33.6%) had malaria as the primary clinical diagnosis. Neurological involvement was observed in 9313 children (47.6%) and manifested as seizures (6563/17,517 [37.5%]), agitation (316/11,193 [2.8%]), prostration (3223/15,643 [20.6%]), and impaired consciousness or coma (2129/16,080 [13.2%]). In children younger than 5 years, the mean annual incidence of admissions with malaria was 2694 per 100,000 persons and the incidence of malaria with neurological involvement was 1156 per 100,000 persons. However, readmissions may have led to a 10% overestimate in incidence. Children with neurological involvement were older (median, 26 [interquartile range {IQR}, 15-41] vs 21 [IQR, 10-40] months; P<.001), had a shorter duration of illness (median, 2 [IQR, 1-3] vs 3 [IQR, 2-3] days; P<.001), and a higher geometric mean parasite density (42.0 [95% confidence interval {CI}, 40.0-44.1] vs 30.4 [95% CI, 29.0-31.8] x 10(3)/microL; P<.001). Factors independently associated with neurological involvement included past history of seizures (adjusted odds ratio [AOR], 3.50; 95% CI, 2.78-4.42), fever lasting 2 days or less (AOR, 2.02; 95% CI, 1.64-2.49), delayed capillary refill time (AOR, 3.66; 95% CI, 2.40-5.56), metabolic acidosis (AOR, 1.55; 95% CI, 1.29-1.87), and hypoglycemia (AOR, 2.11; 95% CI, 1.31-3.37). Mortality was higher in patients with neurological involvement (4.4% [95% CI, 4.2%-5.1%] vs 1.3% [95% CI, 1.1%-1.5%]; P<.001). At discharge, 159 (2.2%) of 7281 patients had neurological deficits.
Neurological involvement is common in children in Kenya with acute falciparum malaria, and is associated with metabolic derangements, impaired perfusion, parasitemia, and increased mortality and neurological sequelae. This study suggests that falciparum malaria exposes many African children to brain insults.
恶性疟原虫似乎特别容易侵犯脑部,但神经受累的负担、危险因素及全面情况尚未得到系统描述。
确定非洲急性恶性疟儿童神经受累的发病率,并描述其临床表型及结局。
设计、地点和患者:回顾1992年1月至2004年12月肯尼亚一家地区医院收治的所有14岁以下疟疾患儿的记录。神经受累定义为惊厥发作、烦躁不安、极度虚弱、意识障碍或昏迷。
神经受累的发病率、模式及结局。
在收治的58239名儿童中,19560名(33.6%)以疟疾作为主要临床诊断。9313名儿童(47.6%)出现神经受累,表现为惊厥发作(6563/17517 [37.5%])、烦躁不安(316/11193 [2.8%])、极度虚弱(3223/15643 [20.6%])、意识障碍或昏迷(2129/16080 [13.2%])。5岁以下儿童中,疟疾住院的年平均发病率为每10万人2694例,疟疾伴神经受累的发病率为每10万人1156例。然而,再次入院可能导致发病率高估10%。神经受累儿童年龄较大(中位数26 [四分位间距{IQR},15 - 41]个月对21 [IQR,10 - 40]个月;P <.001),病程较短(中位数2 [IQR,1 - 3]天对3 [IQR,2 - 3]天;P <.001),几何平均寄生虫密度较高(42.0 [95%置信区间{CI},40.0 - 44.1]对30.4 [95% CI,29.0 - 31.8]×10³/μL;P <.001)。与神经受累独立相关的因素包括既往惊厥病史(调整优势比[AOR],3.50;95% CI,2.78 - 4.42)、发热持续2天或更短(AOR,2.02;95% CI,1.64 - 2.49)、毛细血管再充盈时间延迟(AOR,3.66;95% CI,2.40 - 5.56)、代谢性酸中毒(AOR,1.55;95% CI,1.29 - 1.87)及低血糖(AOR,2.11;95% CI,1.31 - 3.37)。神经受累患者的死亡率较高(4.4% [95% CI,4.2% - 5.1%]对1.3% [95% CI,1.1% - 1.5%];P <.001)。出院时,7281例患者中有159例(2.2%)存在神经功能缺损。
在肯尼亚,急性恶性疟儿童中神经受累很常见,且与代谢紊乱、灌注受损、寄生虫血症、死亡率增加及神经后遗症相关。这项研究表明,恶性疟使许多非洲儿童面临脑部损伤。